Subcutaneous bleeding after coronary stent implantation is generally considered to be related to hematoma at the puncture site and bleeding risk. The hematoma at the puncture site should be treated with local compression, and the routine blood test should be repeated to observe whether anemia occurs; the bleeding caused by taking aspirin and other antiplatelet drugs should be repeated in the hospital, and the antiplatelet drug treatment plan should be changed according to the doctor’s instruction.
1. Hematoma at the puncture site: a common complication caused by puncture of the femoral artery, patients show subcutaneous bleeding at the puncture site, swelling, pain, generally can be treated with local compression, if necessary, review the blood routine to observe whether anemia occurs, if the anemia is serious, if necessary, blood transfusion therapy.
2. Bleeding risk: Generally, within one year after coronary stent implantation, two kinds of antiplatelet drugs such as aspirin, clopidogrel, tegretol, etc. are needed to prevent thrombosis, which may cause bleeding risk, which may be manifested as subcutaneous bleeding, nosebleed, gum bleeding, etc. Generally, it is necessary to go to the hospital to check the blood routine and other related examinations, and change the antiplatelet treatment plan as prescribed by the doctor.
The basic principle of coronary stent implantation is to puncture the coronary artery, and under X-ray fluoroscopy, use a special catheter and guide wire to deliver the stent to the narrowed or occluded part of the coronary artery, to open up the blood vessel to restore blood flow. If patients experience subcutaneous bleeding after the procedure, it is recommended that they visit a hospital as soon as possible to identify the cause and follow the doctor’s instructions.